This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​EU conditionally clears IMS Health's acquisition of parts of Cegedim

( December 19, 2014, 16:35 GMT | Official Statement) -- MLex Summary: The European Commission has cleared IMS Health's purchase of assets from Cegedim, a company involved in market research for the pharmaceuticals industry. The clearance was granted on condition that IMS sell parts of its primary market research business and grant access to the underlying structure of its sales tracking data. These commitments remedy the EU watchdog's concern that the deal could lead to less choice and higher prices for customers.Mergers: Commission approves IMS Health's acquisition of parts of Cegedim, subject to conditions...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login